Ketterling RP - Search Results

1

Characterizing false-positive fluorescence in situ hybridization results by mate-pair sequencing in a patient with chronic myeloid leukemia and progression to myeloid blast crisis.

Lopes JL, Webley M, Pitel BA, Pearce KE, Smadbeck JB, Johnson SH, Vasmatzis G, Sukov WR, Greipp PT, Hoppman NL, Ketterling RP, Baughn LB, Finn L, Peterson JF. Lopes JL, et al. Among authors: ketterling rp. Cancer Genet. 2020 May;243:48-51. doi: 10.1016/j.cancergen.2020.02.008. Epub 2020 Mar 17. Cancer Genet. 2020. PMID: 32272434

2

New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia.

Brockman SR, Paternoster SF, Ketterling RP, Dewald GW. Brockman SR, et al. Among authors: ketterling rp. Cancer Genet Cytogenet. 2003 Sep;145(2):144-51. doi: 10.1016/s0165-4608(03)00061-x. Cancer Genet Cytogenet. 2003. PMID: 12935927

3

Microduplication 22q11.2, an emerging syndrome: clinical, cytogenetic, and molecular analysis of thirteen patients.

Ensenauer RE, Adeyinka A, Flynn HC, Michels VV, Lindor NM, Dawson DB, Thorland EC, Lorentz CP, Goldstein JL, McDonald MT, Smith WE, Simon-Fayard E, Alexander AA, Kulharya AS, Ketterling RP, Clark RD, Jalal SM. Ensenauer RE, et al. Among authors: ketterling rp. Am J Hum Genet. 2003 Nov;73(5):1027-40. doi: 10.1086/378818. Epub 2003 Oct 2. Am J Hum Genet. 2003. PMID: 14526392 Free PMC article.

4

Preclinical validation of fluorescence in situ hybridization assays for clinical practice.

Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR, Dewald GW. Wiktor AE, et al. Among authors: ketterling rp. Genet Med. 2006 Jan;8(1):16-23. doi: 10.1097/01.gim.0000195645.00446.61. Genet Med. 2006. PMID: 16418595 Free article.

5

Utility of peripheral blood dual color, double fusion fluorescent in situ hybridization for BCR/ABL fusion to assess cytogenetic remission status in chronic myeloid leukemia.

Landstrom AP, Ketterling RP, Knudson RA, Tefferi A. Landstrom AP, et al. Among authors: ketterling rp. Leuk Lymphoma. 2006 Oct;47(10):2055-61. doi: 10.1080/10428190600783551. Leuk Lymphoma. 2006. PMID: 17071476

6

Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.

Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP. Sukov WR, et al. Among authors: ketterling rp. Mod Pathol. 2007 May;20(5):592-603. doi: 10.1038/modpathol.3800776. Epub 2007 Mar 30. Mod Pathol. 2007. PMID: 17396140 Free article.

7

Automated Duet spot counting system and manual technologist scoring using dual-fusion fluorescence in situ hybridization (D-FISH) strategy: comparison and application to FISH minimal residual disease testing in patients with chronic myeloid leukemia.

Knudson RA, Shearer BM, Ketterling RP. Knudson RA, et al. Among authors: ketterling rp. Cancer Genet Cytogenet. 2007 May;175(1):8-18. doi: 10.1016/j.cancergencyto.2006.12.006. Cancer Genet Cytogenet. 2007. PMID: 17498552

8

Philadelphia chromosome mosaicism at diagnosis in chronic myeloid leukemia: clinical correlates and effect on imatinib mesylate treatment outcome.

Landstrom AP, Knudson RA, Dewald GW, Ketterling RP, Tefferi A. Landstrom AP, et al. Among authors: ketterling rp. Leuk Lymphoma. 2007 Nov;48(11):2137-40. doi: 10.1080/10428190701618284. Leuk Lymphoma. 2007. PMID: 17926177

9

Validation of a new three-color fluorescence in situ hybridization (FISH) method to detect CHIC2 deletion, FIP1L1/PDGFRA fusion and PDGFRA translocations.

Fink SR, Belongie KJ, Paternoster SF, Smoley SA, Pardanani AD, Tefferi A, Van Dyke DL, Ketterling RP. Fink SR, et al. Among authors: ketterling rp. Leuk Res. 2009 Jun;33(6):843-6. doi: 10.1016/j.leukres.2008.11.016. Epub 2008 Dec 31. Leuk Res. 2009. PMID: 19118897

10

CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.

Sukov WR, Ketterling RP, Lager DJ, Carlson AW, Sinnwell JP, Chow GK, Jenkins RB, Cheville JC. Sukov WR, et al. Among authors: ketterling rp. Hum Pathol. 2009 Sep;40(9):1296-303. doi: 10.1016/j.humpath.2009.01.016. Epub 2009 Apr 22. Hum Pathol. 2009. PMID: 19386349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page